Parkinson's Disease Treatment Market May See a Big Move| Lundbeck, Sun Pharma, Teva

Advance Market Analytics published a new research publication on "Parkinson's Disease Treatment Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Parkinson's Disease Treatment market was mainly driven by the increasing R&D spending across the world.

Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/33874-global-and-regional-parkinsons-disease-treatment-market?utm_source=Kavita_OpenPR&utm_id=Kavita

Some of the key players profiled in the study are: GSK (United Kingdom), Merck (United States), Novartis AG (Switzerland), Teva (Israel), Boehringer Ingelheim (Germany), Impax Laboratories (United States), Abbvie (United States), Valeant Pharmaceuticals (Canada), Lundbeck (Denmark), Sun Pharma (India).

Scope of the Report of Parkinson's Disease Treatment
Parkinson's disease is a type of chronic and progressive movement disorder that includes malfunction and death of vital nerves cells in the brain, termed as neurons. Some of these dying neurons yield dopamine, a chemical that sends messages to the part of the brain, which controls coordination and movement. As Parkinson's disease progresses, the amount of dopamine produced in the brain decreases, leaving a person unable to control movement normally. Some of the studies have found that genetic factors, and environmental factors can also be caused of Parkinson's disease. Environmental factors such as exposure to environmental toxin or injury may possess the risk of Parkinson's disease. According to National Institute of Environmental Health Sciences, 0.5 million people of the US currently have the disease, and prevalence is rising with the population ages. The major endeavour of the Parkinson's illness treatment is to offer control on symptoms and signs, for instance, difficulty with walking, shakiness in hands, slowness of movement, and so on.

In December 2023, Pfizer and University of California, San Diego partnerd to advance research on using stem cell therapy for Parkinson's disease, aiming to restore lost dopamine-producing neurons.
In October 2023, First non-invasive ultrasound therapy approved in Europe where ultrasound stimulation device targets specific brain regions, offering a non-surgical option for managing tremor in Parkinson's disease.

The titled segments and sub-section of the market are illuminated below: by Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), Patient Care Setting (Hospitals, Clinics), Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, Mao Inhibitors, Comt Inhibitors, Anticholinergics, Other Drugs)

Market Drivers:
Growth in Aging Population and the Associated Increase in the Prevalence of Parkinson's disease
Government Funding for Research

Market Trends:
According to Parkinson.org More than 10 million people a year are living with Parkinson's disease
Medications of individual costs around 2500 USD a year, and therapeutic surgery costs around 100,000 USD for individual

Opportunities:
Patent Expiry of Branded Drugs
Strong Drug Pipeline

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Have Any Questions Regarding Global Parkinson's Disease Treatment Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/33874-global-and-regional-parkinsons-disease-treatment-market?utm_source=Kavita_OpenPR&utm_id=Kavita

Strategic Points Covered in Table of Content of Global Parkinson's Disease Treatment Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Parkinson's Disease Treatment market
Chapter 2: Exclusive Summary - the basic information of the Parkinson's Disease Treatment Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Parkinson's Disease Treatment
Chapter 4: Presenting the Parkinson's Disease Treatment Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country 2015-2020
Chapter 6: Evaluating the leading manufacturers of the Parkinson's Disease Treatment market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2023-2028)
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

finally, Parkinson's Disease Treatment Market is a valuable source of guidance for individuals and companies.

Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/33874-global-and-regional-parkinsons-disease-treatment-market?utm_source=Kavita_OpenPR&utm_id=Kavita

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia.

Contact Us:
Craig Francis (PR & Marketing Manager)
AMA Research & Media LLP
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA - 08837
Phone: +1 201 565 3262, +44 161 818 8166
sales@advancemarketanalytics.com

About Author:
Advance Market Analytics is Global leaders of Market Research Industry provides the quantified B2B research to Fortune 500 companies on high growth emerging opportunities which will impact more than 80% of worldwide companies' revenues.
Our Analyst is tracking high growth study with detailed statistical and in-depth analysis of market trends & dynamics that provide a complete overview of the industry. We follow an extensive research methodology coupled with critical insights related industry factors and market forces to generate the best value for our clients. We Provides reliable primary and secondary data sources, our analysts and consultants derive informative and usable data suited for our clients business needs. The research study enable clients to meet varied market objectives a from global footprint expansion to supply chain optimization and from competitor profiling to M&As.

This release was published on openPR.